KDM6A (Lysine-specific demethylase 6A) variants and mutations
KDM6A (also known as Lysine-specific demethylase 6A) is a human protein-coding gene encoding a lysine-specific demethylase 6A protein. It removes repressive H3K27 methylation and also contributes to chromatin regulation through demethylase-independent interactions. Germline loss-of-function variants cause Kabuki syndrome type 2, while somatic alterations occur in multiple cancers. This analysis covers 4,172 KDM6A variants and mutations. Of these, 18% have computational variant effect predictions. Disease context includes Kabuki syndrome 2, Kabuki syndrome, and urinary bladder cancer. Example KDM6A variants include K2K, S3F, and S3Y.
Variant analysis overview
- Gene: KDM6A
- Protein: Lysine-specific demethylase 6A
- UniProt accession: O15550
- Organism: Homo sapiens
- Variants analyzed: 4172
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 3,991 unspecified-consequence records; 69 synonymous variants; 90 missense variants; 8 stop-gained variants; 4 in-frame deletions; 1 in-frame insertions; 4 frameshift variants; 5 splice-region variants
- Prediction scores: 732 variants have prediction scores (18% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Kabuki syndrome 2, Kabuki syndrome, urinary bladder cancer, urinary bladder carcinoma, prostate adenocarcinoma, hereditary disease, Kabuki syndrome 1, squamous cell lung carcinoma, neurodevelopmental disorder, bladder transitional cell carcinoma, urothelial carcinoma, lung carcinoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 7 binding sites; 5 post-translational modification sites.
- Structural context: 476 variants have structural context.
- PTM context: 27 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable KDM6A variants
Examples include K2K, S3F, S3Y, S3S, C4W, C4S, C4C, G5R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- K2K (p.Lys2Lys), gnomAD X-44873557-A-G, CADD 14.80
- S3F (p.Ser3Phe), ExAC rs778311486, gnomAD rs778311486, CADD 26.50, PolyPhen-2 1.00
- S3Y (p.Ser3Tyr), gnomAD X-44873559-C-A, CADD 25.80, PolyPhen-2 1.00
- S3S (p.Ser3Ser), rs1359983262, gnomAD X-44873560-C-T, CADD 15.00
- C4W (p.Cys4Trp), TOPMed rs1291254847, gnomAD rs1291254847
- C4S (p.Cys4Ser), gnomAD X-44873561-T-A, CADD 25.20, PolyPhen-2 0.00
- C4C (p.Cys4Cys), rs1291254847, gnomAD X-44873563-C-T, CADD 14.90
- G5R (p.Gly5Arg), TOPMed rs1413921299, gnomAD rs1413921299, CADD 27.40, PolyPhen-2 0.87, Uncertain significance, Kabuki syndrome 2
- G5G (p.Gly5Gly), rs749368573, gnomAD X-44873566-A-T, CADD 15.50
- S7L (p.Ser7Leu), cosmic curated COSV65040, ExAC rs770931883, TOPMed rs770931883, gnomAD rs770931883, CADD 27.10, PolyPhen-2 0.99, Uncertain significance
- S7P (p.Ser7Pro), Ensembl rs2146440721
- S7W (p.Ser7Trp), rs770931883, ClinGen CA10392090, cosmic curated COSV10093, ClinVar RCV001581921, CADD 27.30, PolyPhen-2 1.00, Uncertain significance, not provided; Inborn genetic diseases; Kabuki syndrome 2
- S7* (p.Ser7Ter), gnomAD X-44873571-C-A, CADD 36.00
- S7S (p.Ser7Ser), rs2146440794, gnomAD X-44873572-G-A, CADD 14.30
- L8P (p.Leu8Pro), Ensembl rs2146440837
- L8I (p.Leu8Ile), gnomAD X-44873573-C-A, CADD 22.90, PolyPhen-2 0.30
- L8V (p.Leu8Val), gnomAD X-44873573-C-G, CADD 19.40, PolyPhen-2 0.30
- L8L (p.Leu8Leu), rs2031055969, gnomAD X-44873575-C-T, CADD 13.60
- A9P (p.Ala9Pro), rs2146440966, ClinGen CA413020117, ClinVar RCV002297233, Ensembl rs2146440966, AlphaMissense 0.15, MetaLR 0.14, Uncertain significance, Kabuki syndrome 2
- A9V (p.Ala9Val), gnomAD X-44873577-C-T, CADD 23.70, PolyPhen-2 0.17
- T10A (p.Thr10Ala), Ensembl rs1332106985, CADD 18.90, PolyPhen-2 0.01
- T10P (p.Thr10Pro), Ensembl rs1332106985, CADD 24.00, PolyPhen-2 0.58
- p.Thr10 Ala13del, rs769370817, gnomAD X-44873574-TCGCTA, CADD 20.70
- T10T (p.Thr10Thr), rs2031059053, gnomAD X-44873581-C-A, CADD 13.90
- A11P (p.Ala11Pro), Ensembl rs2146441171
- A11S (p.Ala11Ser), Ensembl rs2146441171
- A11T (p.Ala11Thr), NCI-TCGA TCGA novel, Ensembl rs2146441171, CADD 22.80, PolyPhen-2 1.00, Variant assessed as somatic; moderate impact.
- A11A (p.Ala11Ala), rs774504643, gnomAD X-44873584-C-A, CADD 14.30
- A12T (p.Ala12Thr), Ensembl rs2146441261, Uncertain significance, Kabuki syndrome 2
- A12G (p.Ala12Gly), gnomAD X-44873586-C-G, CADD 23.20, PolyPhen-2 0.99
- A13S (p.Ala13Ser), gnomAD rs1321489657, CADD 19.00, PolyPhen-2 1.00, Uncertain significance, Kabuki syndrome 2
- A13T (p.Ala13Thr), gnomAD rs1321489657, CADD 21.30, PolyPhen-2 1.00, Uncertain significance, Kabuki syndrome 2
- A13A (p.Ala13Ala), rs2031062522, gnomAD X-44873590-T-C, CADD 11.20
- A14P (p.Ala14Pro), Ensembl rs2146441483
- A14T (p.Ala14Thr), Ensembl rs2146441483, CADD 23.80, PolyPhen-2 1.00
- A14V (p.Ala14Val), Ensembl rs2146441593
- p.Ala14 Ala17del, rs749062014, gnomAD X-44873579-ACCGCC, CADD 20.30
- A14A (p.Ala14Ala), gnomAD X-44873593-C-T, CADD 14.50
- A15D (p.Ala15Asp), gnomAD rs1212270608, CADD 25.90, PolyPhen-2 0.56
- A15P (p.Ala15Pro), Ensembl rs2031064287, Uncertain significance
- A15T (p.Ala15Thr), rs2031064287, ClinGen CA413020152, ClinVar RCV003133840, Ensembl rs2031064287, AlphaMissense 0.12, MetaLR 0.04, Uncertain significance, Kabuki syndrome 2
- A15V (p.Ala15Val), gnomAD X-44873595-C-T, CADD 23.80, PolyPhen-2 0.20
- A15A (p.Ala15Ala), rs746032827, gnomAD X-44873596-C-T, CADD 15.40
- A16G (p.Ala16Gly), rs1007509134, ClinGen CA329555540, ClinVar RCV003397631, ClinVar RCV005062880, CADD 19.80, PolyPhen-2 0.33, Uncertain significance, KDM6A-related disorder; Kabuki syndrome 2
- A16S (p.Ala16Ser), Ensembl rs2031066127, CADD 19.60, PolyPhen-2 0.58
- A16T (p.Ala16Thr), Ensembl rs2031066127, CADD 22.60, PolyPhen-2 0.29
- A16V (p.Ala16Val), TOPMed rs1007509134, gnomAD rs1007509134, CADD 22.30, PolyPhen-2 0.01, Uncertain significance
- A16A (p.Ala16Ala), rs772375300, gnomAD X-44873599-C-T, CADD 14.70
- A17T (p.Ala17Thr), rs1018780128, ClinGen CA329555541, ClinVar RCV001909661, ClinVar RCV006362926, CADD 22.70, PolyPhen-2 0.41, Conflicting interpretations, Inborn genetic diseases; Kabuki syndrome 2
- A17del (p.Ala17del), rs1467702310, gnomAD X-44873579-ACCG-A, CADD 20.40
- p.Ala17dup, rs1354071758, gnomAD X-44873587-C-CGCT, CADD 19.40
- F18L (p.Phe18Leu), rs2031069174, ClinGen CA413020174, ClinVar RCV003853854, TOPMed rs2031069174, CADD 22.40, PolyPhen-2 0.00, Uncertain significance, Kabuki syndrome 2
- F18V (p.Phe18Val), gnomAD X-44873603-T-G, CADD 22.40, PolyPhen-2 0.13
- G19S (p.Gly19Ser), TOPMed rs1459076968, gnomAD rs1459076968, CADD 24.30, PolyPhen-2 1.00
- G19C (p.Gly19Cys), gnomAD X-44873606-G-T, CADD 24.80, PolyPhen-2 1.00
- D20N (p.Asp20Asn), TOPMed rs1271145433
- D20V (p.Asp20Val), Ensembl rs1243838377, Uncertain significance, Kabuki syndrome 2
- D20E (p.Asp20Glu), gnomAD X-44873611-T-G, CADD 25.90, PolyPhen-2 0.99
- D20D (p.Asp20Asp), rs1239808864, gnomAD X-44873611-T-C, CADD 14.70
- E21D (p.Glu21Asp), rs2519216374, ClinGen CA413020195, ClinVar RCV003325135, Uncertain significance, not provided
- E21A (p.Glu21Ala), gnomAD X-44873613-A-C, CADD 26.20, PolyPhen-2 0.99
- E21E (p.Glu21Glu), gnomAD X-44873614-G-A, CADD 13.30
- E22A (p.Glu22Ala), rs760601613, ClinGen CA10392100, ClinVar RCV001291708, ExAC rs760601613, CADD 22.60, PolyPhen-2 0.01, Conflicting interpretations, Kabuki syndrome 2
- E22D (p.Glu22Asp), NCI-TCGA TCGA novel, CADD 21.90, PolyPhen-2 0.28, Variant assessed as somatic; moderate impact.
- E22G (p.Glu22Gly), cosmic curated COSV65039, ExAC rs760601613, TOPMed rs760601613, gnomAD rs760601613, CADD 23.00, PolyPhen-2 0.17, Benign, Kabuki syndrome 2
- E22E (p.Glu22Glu), rs1222338105, gnomAD X-44873617-A-G, CADD 14.50
- K23N (p.Lys23Asn), rs2031074739, ClinGen CA413020210, ClinVar RCV003078992, NCI-TCGA TCGA novel, AlphaMissense 0.35, MetaLR 0.30, Uncertain significance, Kabuki syndrome 2
- K23E (p.Lys23Glu), gnomAD X-44873618-A-G, CADD 22.70, PolyPhen-2 0.99
- K24E (p.Lys24Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K24Q (p.Lys24Gln), gnomAD rs1186964201, CADD 26.70, PolyPhen-2 1.00
- A26G (p.Ala26Gly), Ensembl rs2146442630
- A26T (p.Ala26Thr), Ensembl rs2146442583
- A26V (p.Ala26Val), Ensembl rs2146442630
- A26A (p.Ala26Ala), gnomAD X-44873629-G-T, CADD 14.90
- A27E (p.Ala27Glu), Ensembl rs201220623
- A27G (p.Ala27Gly), Ensembl rs201220623
- A27T (p.Ala27Thr), Ensembl rs2146442686
- A27V (p.Ala27Val), Ensembl rs201220623, CADD 24.20, PolyPhen-2 1.00
- G28R (p.Gly28Arg), Ensembl rs2146442821
- G28V (p.Gly28Val), gnomAD X-44873634-G-T, CADD 27.80, PolyPhen-2 1.00
- K29R (p.Lys29Arg), rs2519216898, ClinGen CA413020249, ClinVar RCV003343533, CADD 26.80, PolyPhen-2 0.99, Uncertain significance, Inborn genetic diseases
- K29K (p.Lys29Lys), rs776639769, gnomAD X-44873638-A-G, CADD 14.90
- A30G (p.Ala30Gly), NCI-TCGA Cosmic COSV1009, cosmic curated COSV10093, NCI-TCGA Cosmic COSV6504, gnomAD rs1394985803, Variant assessed as somatic; moderate impact.
- A30T (p.Ala30Thr), rs6529, ClinGen CA160284, cosmic curated COSV65039, ClinVar RCV000121284, CADD 25.70, PolyPhen-2 1.00, Benign
- A30V (p.Ala30Val), cosmic curated COSV65046, gnomAD rs1394985803, CADD 26.80, PolyPhen-2 1.00
- A30R (p.Ala30Arg), rs1413057347, gnomAD X-44873634-GA-G, CADD 27.50
- A30A (p.Ala30Ala), gnomAD X-44873641-G-A, CADD 15.00
- S31G (p.Ser31Gly), Ensembl rs2146443086
- S31I (p.Ser31Ile), Ensembl rs2031078966
- S31R (p.Ser31Arg), gnomAD X-44873644-C-A, CADD 22.40, PolyPhen-2 1.00
- S31S (p.Ser31Ser), rs764602605, gnomAD X-44873644-C-T, CADD 15.40
- G32S (p.Gly32Ser), Ensembl rs2146443187, CADD 22.30, PolyPhen-2 0.58
- G32C (p.Gly32Cys), gnomAD X-44873645-G-T, CADD 26.60, PolyPhen-2 0.97
- G32G (p.Gly32Gly), rs2031080010, gnomAD X-44873647-C-T, CADD 16.40
- E33K (p.Glu33Lys), Ensembl rs2146443260
- E33* (p.Glu33Ter), gnomAD X-44873648-G-T, CADD 36.00
- E33D (p.Glu33Asp), gnomAD X-44873650-G-C, CADD 23.60, PolyPhen-2 0.01
- S34G (p.Ser34Gly), Ensembl rs2146443287
- S34I (p.Ser34Ile), rs2519217214, ClinGen CA2580100965, ClinVar RCV002296611, Uncertain significance, Kabuki syndrome 2
- S34R (p.Ser34Arg), Ensembl rs2146443355, CADD 23.70, PolyPhen-2 0.72
- S34T (p.Ser34Thr), rs749979159, ClinGen CA10392103, ClinVar RCV004409157, ClinVar RCV004759383, CADD 17.80, PolyPhen-2 0.22, Uncertain significance, Inborn genetic diseases; not provided
- S34N (p.Ser34Asn), gnomAD X-44873652-G-A, CADD 23.30, PolyPhen-2 0.17
- S34S (p.Ser34Ser), rs2146443355, gnomAD X-44873653-C-T, CADD 15.40
- E35* (p.Glu35Ter), TOPMed rs2031081534, gnomAD rs2031081534, CADD 36.00
- E35K (p.Glu35Lys), gnomAD X-44873654-G-A, CADD 22.70, PolyPhen-2 0.01
- E36D (p.Glu36Asp), cosmic curated COSV10468, gnomAD rs1433062891, CADD 24.30, PolyPhen-2 0.99
- E36G (p.Glu36Gly), Ensembl rs2146443456
- A37E (p.Ala37Glu), TOPMed rs1601994984
- A37V (p.Ala37Val), NCI-TCGA TCGA novel, TOPMed rs1601994984, CADD 23.20, PolyPhen-2 0.32, Uncertain significance, Kabuki syndrome 2; Inborn genetic diseases
- A37S (p.Ala37Ser), gnomAD X-44873660-G-T, CADD 22.20, PolyPhen-2 0.13
- A37A (p.Ala37Ala), rs1271271423, gnomAD X-44873662-G-A, CADD 15.30
- S38A (p.Ser38Ala), Ensembl rs2146443588
- S38C (p.Ser38Cys), Ensembl rs2146443655
- S38P (p.Ser38Pro), Ensembl rs2146443588, CADD 22.80, PolyPhen-2 0.00
- S38T (p.Ser38Thr), Ensembl rs2146443588
- S38Y (p.Ser38Tyr), rs2146443655, ClinGen CA413020312, ClinVar RCV003404338, CADD 22.50, PolyPhen-2 0.75, Uncertain significance, KDM6A-related disorder
- S38F (p.Ser38Phe), gnomAD X-44873664-C-T, CADD 22.60, PolyPhen-2 0.75
- S38S (p.Ser38Ser), gnomAD X-44873665-C-A, CADD 14.50
- P39L (p.Pro39Leu), ExAC rs757954946, TOPMed rs757954946, gnomAD rs757954946, CADD 22.50, PolyPhen-2 0.01
- P39A (p.Pro39Ala), gnomAD X-44873666-C-G, CADD 19.20, PolyPhen-2 0.17
- P39T (p.Pro39Thr), gnomAD X-44873666-C-A, CADD 20.80, PolyPhen-2 0.37
- P39H (p.Pro39His), gnomAD X-44873667-C-A, CADD 24.10, PolyPhen-2 0.85
- P39P (p.Pro39Pro), rs1295453686, gnomAD X-44873668-C-T, CADD 14.20
- S40G (p.Ser40Gly), TOPMed rs2031085490, CADD 23.90, PolyPhen-2 0.99
- S40P (p.Ser40Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S40R (p.Ser40Arg), gnomAD rs1335937695, CADD 23.00, PolyPhen-2 1.00
- S40A (p.Ser40Ala), gnomAD X-44873663-TC-T, CADD 27.20
- S40I (p.Ser40Ile), gnomAD X-44873670-G-T, CADD 23.80, PolyPhen-2 1.00
- S40N (p.Ser40Asn), gnomAD X-44873670-G-A, CADD 22.10, PolyPhen-2 0.99
- S40S (p.Ser40Ser), rs1335937695, gnomAD X-44873671-C-T, CADD 14.80
- L41M (p.Leu41Met), gnomAD rs868731205, CADD 24.90, PolyPhen-2 1.00
- L41L (p.Leu41Leu), rs868731205, gnomAD X-44873672-C-T, CADD 14.00
- L41P (p.Leu41Pro), gnomAD X-44873673-T-C, CADD 29.50, PolyPhen-2 1.00
- T42I (p.Thr42Ile), Ensembl rs2146443888
- T42K (p.Thr42Lys), gnomAD X-44873676-C-A, CADD 26.50, PolyPhen-2 1.00
- T42T (p.Thr42Thr), rs1281700540, gnomAD X-44873677-A-G, CADD 15.50
- A43T (p.Ala43Thr), cosmic curated COSV10531, Ensembl rs1449970088, CADD 22.80, PolyPhen-2 0.24
- A43V (p.Ala43Val), Ensembl rs2146444005, CADD 22.00, PolyPhen-2 0.01
- A43S (p.Ala43Ser), gnomAD X-44873678-G-T, CADD 22.50, PolyPhen-2 0.17
- A43D (p.Ala43Asp), gnomAD X-44873679-C-A, CADD 23.60, PolyPhen-2 0.58
- A43A (p.Ala43Ala), gnomAD X-44873680-C-T, CADD 14.30
- E44K (p.Glu44Lys), cosmic curated COSV10093, Ensembl rs2146444057, AlphaMissense 0.13, MetaLR 0.24
- E44Q (p.Glu44Gln), rs2146444057, ClinGen CA413020345, ClinVar RCV003156431, AlphaMissense 0.13, MetaLR 0.24, Uncertain significance, not provided
- E44* (p.Glu44Ter), gnomAD X-44873681-G-T, CADD 36.00
- E44G (p.Glu44Gly), gnomAD X-44873682-A-G, CADD 27.00, PolyPhen-2 0.18
- E44E (p.Glu44Glu), gnomAD X-44873683-G-A, CADD 10.50
- E45K (p.Glu45Lys), gnomAD rs1448211324, AlphaMissense 0.97, MetaLR 0.37
- E45Q (p.Glu45Gln), rs1448211324, ClinGen CA413020353, ClinVar RCV002467362, AlphaMissense 0.97, MetaLR 0.37, Uncertain significance, not provided
- E45* (p.Glu45Ter), gnomAD X-44873684-G-T, CADD 37.00
- E45V (p.Glu45Val), gnomAD X-44873685-A-T, CADD 33.00, PolyPhen-2 1.00
- E45D (p.Glu45Asp), gnomAD X-44873686-G-T, CADD 24.40, PolyPhen-2 0.99
- R46K (p.Arg46Lys), rs2031089050, ClinGen CA413020362, ClinVar RCV002811146, TOPMed rs2031089050, CADD 22.10, PolyPhen-2 0.98, Uncertain significance, Kabuki syndrome 2
- R46W (p.Arg46Trp), gnomAD rs1215951155, CADD 31.00, PolyPhen-2 1.00
- R46M (p.Arg46Met), gnomAD X-44873688-G-T, CADD 26.80, PolyPhen-2 1.00
- R46S (p.Arg46Ser), gnomAD X-44873689-G-T, CADD 24.90, PolyPhen-2 0.99
- E47G (p.Glu47Gly), rs2031089646, ClinGen CA413020371, ClinVar RCV001254085, Ensembl rs2031089646, CADD 25.60, PolyPhen-2 0.99, Pathogenic, Kabuki syndrome 2
- E47K (p.Glu47Lys), rs2146444183, ClinGen CA413020367, ClinVar RCV001374433, Ensembl rs2146444183, AlphaMissense 0.16, MetaLR 0.32, Uncertain significance, Peripheral precocious puberty
- E47* (p.Glu47Ter), gnomAD X-44873690-G-T, CADD 39.00
- E47E (p.Glu47Glu), rs1236803571, gnomAD X-44873692-G-A, CADD 14.00
- A48E (p.Ala48Glu), TOPMed rs1392945538, gnomAD rs1392945538, CADD 19.70, PolyPhen-2 0.73
- A48S (p.Ala48Ser), rs2519218021, ClinGen CA413020377, ClinVar RCV002286947, Uncertain significance, not provided
- A48V (p.Ala48Val), TOPMed rs1392945538, gnomAD rs1392945538, CADD 21.70, PolyPhen-2 0.01
- A48T (p.Ala48Thr), gnomAD X-44873693-G-A, CADD 22.70, PolyPhen-2 0.28
- A48A (p.Ala48Ala), gnomAD X-44873695-G-C, CADD 14.90
- L49H (p.Leu49His), Ensembl rs2146444355
- L49P (p.Leu49Pro), Ensembl rs2146444355
- L49R (p.Leu49Arg), Ensembl rs2146444355
- L49V (p.Leu49Val), Ensembl rs2146444331
- L49L (p.Leu49Leu), rs766103037, gnomAD X-44873698-C-T, CADD 14.30
- G50A (p.Gly50Ala), TOPMed rs923984398, gnomAD rs923984398, Likely benign
- G50D (p.Gly50Asp), rs923984398, ClinGen CA329555544, ClinVar RCV001800030, ClinVar RCV002541333, CADD 22.50, PolyPhen-2 0.68, Conflicting interpretations, not provided; Kabuki syndrome 2; Inborn genetic diseases
- G50S (p.Gly50Ser), rs1190008554, ClinGen CA413020387, ClinVar RCV002778646, ClinVar RCV006612735, CADD 21.00, PolyPhen-2 0.05, Likely benign, Inborn genetic diseases; Kabuki syndrome 2
- G50G (p.Gly50Gly), rs1472145906, gnomAD X-44873701-C-T, CADD 14.00
- G51* (p.Gly51Ter), rs886043476, ClinGen CA10605565, ClinVar RCV000338872, Ensembl rs886043476, Pathogenic
- G51A (p.Gly51Ala), rs1352040501, ClinGen CA413020395, ClinVar RCV003643286, AlphaMissense 0.12, MetaLR 0.35, Uncertain significance, Kabuki syndrome 2
- G51E (p.Gly51Glu), cosmic curated COSV10093, TOPMed rs1352040501, AlphaMissense 0.12, MetaLR 0.35, Uncertain significance, not provided; Kabuki syndrome 2
- G51V (p.Gly51Val), rs1352040501, ClinGen CA413020396, ClinVar RCV003644129, TOPMed rs1352040501, AlphaMissense 0.12, MetaLR 0.35, Uncertain significance, Kabuki syndrome 2
- G51R (p.Gly51Arg), gnomAD X-44873702-G-A, CADD 27.00, PolyPhen-2 0.87
- G51G (p.Gly51Gly), gnomAD X-44873704-A-G, CADD 15.60
- L52M (p.Leu52Met), gnomAD X-44873705-C-A, CADD 21.90, PolyPhen-2 0.07
Public KDM6A analysis runs
- KDM6A analysis run — KDM6A (4,172 variants) — completed 2026-08-19